Neurocentrx Pharma
PrivateLast Round
Seed
Sep 23, 2025
Total Funding Raised
$5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Neurocentrx Pharma is a biopharmaceutical company developing oral ketamine formulations designed to treat patients with mood disorders and other neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurocentrx Pharma Comparables
Compare Neurocentrx Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tasman Therapeutics | 88% | |
| HMNC Brain Health | 85% | |
| AtaiBeckley Inc. | 79% |
Neurocentrx Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 23, 2025 | ||||
| Series A | Sep 23, 2025 | ||||
| VC Round | May 12, 2022 | ||||
| Angel | Mar 20, 2014 |
Neurocentrx Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| o2h ventures | VC Round |
| Equity Gap | VC Round, Angel |
| Meltwind Advisory | VC Round |
| Old College Capital | VC Round |
| Neo Kuma Ventures | VC Round |
| Scottish Investment Bank (Scottish Enterprise) | VC Round |
| Wellcome Trust | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 132% MoM.
- Jul 26, 2026
Monthly visitors grew 163% MoM, reaching 1.5K.
Neurocentrx Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurocentrx Pharma's valuation, stock price, and market status.
Is Neurocentrx Pharma a public or private company?
Neurocentrx Pharma is a private company.
What is the current stock price of Neurocentrx Pharma?
Neurocentrx Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Neurocentrx Pharma worth (valuation)?
Valuation information for Neurocentrx Pharma is not publicly available.
Can I buy Neurocentrx Pharma stock?
Neurocentrx Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurocentrx Pharma's last funding round?
Neurocentrx Pharma's most recent funding round was Series A on September 23, 2025.
Who are the main investors in Neurocentrx Pharma?
Key investors in Neurocentrx Pharma include Wellcome Trust.
Will Neurocentrx Pharma IPO soon?
No public IPO plans have been announced for Neurocentrx Pharma.
How can I track Neurocentrx Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurocentrx Pharma's secondary market activity and sign up for updates.